Mihran Yenikomshian

Boston
Education
M.B.A., F.W. Olin Graduate School of Business, Babson College; B.A., quantitative economics and computer science, Tufts University
Summary of Experience
Mr. Yenikomshian specializes in data analysis and economic modeling, and has consulted on economic and strategic issues to companies in a variety of industries, including pharmaceuticals, medical insurance, blockchain and cryptocurrency, computer software and technology, and cybersecurity. He has extensive experience analyzing large datasets, such as administrative insurance medical claims and transactional software sales data. Mr. Yenikomshian has calculated damages in antitrust, health care product liability, kickback, and off-label pharmaceutical promotion matters, and in a variety of consumer class action cases. He has served as a testifying expert in a criminal matter, provided critiques of data and analytical methodologies in support of rebuttal testimony, and assisted attorneys with discovery, cross-examination strategy, and settlement negotiations. He has also developed interactive software tools to help clients make strategic decisions. Mr. Yenikomshian is a member of the American Bar Association and serves as co-chair of its Big Data Committee and Data Science Working Group, as well as vice chair of its Artificial Intelligence and Robotics Committee. Prior to joining Analysis Group, he was a partner in a software development and staffing technology firm.
Selected Cases
Selected Publishing
-
Mitigating Antitrust Concerns when Competitors Share Data Using Blockchain Technology
Harvard Journal of Law & Technology, Volume 34, Digest Spring 2021
2021Arcelus A, Nocera N, Yenikomshian M
-
Health Cos. Can Reduce FCA Risk by Leveraging Data
Law360, 2021
2021Jenny B, Yenikomshian M, Greenberg PE
-
Real-World Adherence in Patients with Metastatic Colorectal Cancer Treated with Trifluridine plus Tipiracil or Regorafenib
Oncologist, 2020
2020Patel AK, Barghout V, Yenikomshian MA, Germain G, Jacques P, Laliberté F, Duh MS
-
Modeling the potential impact of abuse-deterrent opioids on medical resource utilization
Journal of Medical Economics, 2019
2019Yenikomshian MA, White AG, Carson ME, Jia ZB, Mendoza MR, Roland CL
-
Cardiac arrhythmia detection outcomes among patients monitored with the Zio patch system: a systematic literature review
Current Medical Research and Opinion, 2019
2019Yenikomshian M, Jarvis J, Patton C, Yee C, Mortimer R, Birnbaum H, Topash M
-
Real-world Treatment Patterns Among Patients With Colorectal Cancer Treated With Trifluridine/Tipiracil and Regorafenib
Clinical Colorectal Cancer. 2018 Sep;17(3):e531-e539
2018Patel AK, Duh MS, Barghout V, Yenikomshian MA, Xiao Y, Wynant W, Tabesh M, Fuchs CS
-
Projecting the cost, utilization, and patient care impact of prescribing extended release non-abuse-deterrent opioids to chronic pain patients
Journal of Opioid Management. Sep/Oct 2017;13(5):291-301
2017Yenikomshian MA, White AG, Carson ME, Garrison LP, Oderda GM, Biskupiak JE, Hlavacek PR, Roland CL
-
-
A model to quantify potential medical events avoided and cost savings from abuse deterrent opioids
Journal of Pain, 2016
2016White A, Yenikomshian M, Carson M, Masters E, Roland C
-
The epidemiology of herpes zoster and its complications in Medicare cancer patients
BMC Infect Dis. 2015 Feb 27;15(1):106. doi: 10.1186/s12879-015-0810-6
2015Yenikomshian MA, Guignard AP, Haguinet F, LaCasce AS, Skarin AT, Trahey A, Karner P, Duh MS
-
The economic impact of implementing a multiple inflammatory biomarker-based approach to identify, treat, and reduce cardiovascular risk
J Med Econ. 2015 Apr 1:1-9. [Epub ahead of print]
2015Penn MS, Yenikomshian MA, Cummings AK, Klemes A, Damron JM, Purvis S, Beidelschies M, Birnbaum HG
Events
-
July 16, 2020
-
July 30, 2020
-
September 30, 2020
-
April 1, 2022
-
October 12, 2022
News
-
March 2, 2023
-
May 27, 2022
-
March 29, 2022
-
October 15, 2021
-
August 12, 2021
-
March 16, 2021
-
March 16, 2021
-
AG Feature
A New “Gold Standard”? How Digital Health Technologies Can Be Used to Monitor Patient Progress
-
Health Care Bulletin
Pricing, Litigation, Enforcement: The 2022 Law & Economics Symposium in Review
-
Forum
“The Business of Cybersecurity Is Business”: Kevin Powers on Managing the Risks and Consequences of Cyberattacks and Data Breaches
-
AG Feature
Using Machine Learning in Litigation
-
Case Outcome
Pharmaceutical Off-Label Promotion & Kickbacks Settlements
-
Health Care Bulletin
Machine Learning Algorithms in Health Care Litigation